Introduction of photodynamic therapy for the treatment of neovascular age-related macular degeneration: tracking a moving target

被引：0
|
作者：
B Foot
R Foy
U Chakravarthy
R Wormald
机构：
[1] The Royal College of Ophthalmologists,Research and Development Department
[2] Moorfields Eye Hospital,Department of Reproductive and Development Sciences
[3] University of Edinburgh,undefined
来源：
Eye | 2003年 / 17卷
关键词：
photodynamic therapy; service provision; health technology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objectives To identify changes in referral and treatment patterns of neovascular age-related macular degeneration with photodynamic therapy (PDT) within ophthalmology units in NHS hospitals and assess how beliefs about what would constitute a worthwhile level of clinical benefit had altered over a 12-month period.
引用
收藏
页码：583 / 586
页数：3
相关论文
共 50 条
  • [31] VERTEPORFIN COMBINATION REGIMENS IN THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Shah, Gaurav K.
    Sang, Delia N.
    Hughes, Mark S.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (02): : 133 - 148
  • [32] Combination therapy for neovascular form of age-related macular degeneration with photodynamic therapy and ranizumab-2-year report
    Kraut, Aleksandra
    Sevsek, Davorin
    Mekjavic, Polona Jaki
    Urbancic, Mojca
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2010, 79 : 39 - 45
  • [33] Retrospective review of eyes with neovascular age-related macular degeneration treated with photodynamic therapy with verteporfin and intravitreal triamcinolone
    Fackler, Tamara K.
    Reddy, Shantan
    Bearelly, Srilaxmi
    Stinnett, Sandra
    Fekrat, Sharon
    Cooney, Michael J.
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2006, 35 (10) : 701 - 705
  • [34] The role of choroidal hypoperfusion associated with photodynamic therapy in neovascular age-related macular degeneration and the consequences for combination strategies
    Schmidt-Erfurth, Ursula
    Kiss, Christopher
    Sacu, Stefan
    PROGRESS IN RETINAL AND EYE RESEARCH, 2009, 28 (02) : 145 - 154
  • [35] Preferred therapies for neovascular age-related macular degeneration
    Chiang, Allen
    Regillo, Carl D.
    CURRENT OPINION IN OPHTHALMOLOGY, 2011, 22 (03) : 199 - 204
  • [36] Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration
    Tsuchihashi, Takashi
    Mori, Keisuke
    Ueyama, Kazuhiro
    Yoneya, Shin
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 615 - 620
  • [37] Preferred therapies for neovascular age-related macular degeneration
    Lally, David R.
    Gerstenblith, Adam T.
    Regillo, Carl D.
    CURRENT OPINION IN OPHTHALMOLOGY, 2012, 23 (03) : 182 - 188
  • [38] Low-fluence photodynamic therapy combinations in the treatment of exudative age-related macular degeneration
    Taylan Ozturk
    Hakan Oner
    Ali Osman Saatci
    Suleyman Kaynak
    International Journal of Ophthalmology, 2012, (03) : 377 - 383
  • [39] Intravitreal Aflibercept Versus Photodynamic Therapy in Chinese Patients with Neovascular Age-Related Macular Degeneration: Outcomes of the SIGHT Study
    Li, Xiaoxin
    Chen, Youxin
    Zhang, Junjun
    Xu, Xun
    Zhang, Feng
    Cheung, Chui Ming Gemmy
    Yu, Rui
    Kazmi, Husain
    Sowade, Olaf
    Zeitz, Oliver
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2017, 33 (06) : 435 - 444
  • [40] Transient accumulation of subretinal fluid after half-fluence photodynamic therapy in neovascular age-related macular degeneration
    Min Ho Kim
    Yoo-Ri Chung
    Ji Hun Song
    BMC Ophthalmology, 21
12345